Omega-3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient
- 27 August 2001
- journal article
- case report
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 11 (4) , 295-299
- https://doi.org/10.1016/s0924-977x(01)00098-0
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Use of Psychoactive Medication During Pregnancy and Possible Effects on the Fetus and NewbornPediatrics, 2000
- The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophreniaSchizophrenia Research, 1998
- Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patientsJournal of Affective Disorders, 1998
- The Very Low Birth Weight Premature Infant Is Capable of Synthesizing Arachidonic and Docosahexaenoic Acids from Linoleic and Linolenic AcidsPediatric Research, 1996
- α‐Linolenic Acid Dietary Deficiency Alters Age‐Related Changes of Dopaminergic and Serotoninergic Neurotransmission in the Rat Frontal CortexJournal of Neurochemistry, 1996
- Increased platelet phospholipase A2 activity in schizophreniaSchizophrenia Research, 1995
- The membrane hypothesis of schizophreniaSchizophrenia Research, 1994
- Fatty acid levels in the brains of schizophrenics and normal controlsBiological Psychiatry, 1991
- The Positive and Negative Syndrome Scale (PANSS) for SchizophreniaSchizophrenia Bulletin, 1987
- Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirementsEarly Human Development, 1980